<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type='text/xsl' href='../../ld2webpage.xsl'?>
<LOBBYINGDISCLOSURE2>
  <imported>Y</imported>
  <pages>8</pages>
  <submitURL>
  </submitURL>
  <organizationName>AbbVie, Inc.</organizationName>
  <prefix>
  </prefix>
  <firstName>
  </firstName>
  <lastName>
  </lastName>
  <registrantDifferentAddress>N</registrantDifferentAddress>
  <address1>1399 New York Avenue NW</address1>
  <address2>Suite 600</address2>
  <city>Washington</city>
  <state>DC</state>
  <zip>20005</zip>
  <zipext>
  </zipext>
  <country>USA</country>
  <principal_city>
  </principal_city>
  <principal_state>
  </principal_state>
  <principal_zip>
  </principal_zip>
  <principal_zipext>
  </principal_zipext>
  <principal_country>
  </principal_country>
  <contactIntlPhone>
  </contactIntlPhone>
  <selfSelect>Y</selfSelect>
  <clientName>AbbVie, Inc.</clientName>
  <clientGovtEntity>N</clientGovtEntity>
  <senateID>401049961-12</senateID>
  <houseID>422720000</houseID>
  <reportYear>2016</reportYear>
  <reportType>1A</reportType>
  <terminationDate>
  </terminationDate>
  <noLobbying>
  </noLobbying>
  <income>
  </income>
  <expenses>2570000.00</expenses>
  <expensesMethod>A</expensesMethod>
  <printedName>Paul Ehrlich</printedName>
  <signedDate>4/20/2016 1:53:21 PM</signedDate>
  <alis>
    <ali_info>
      <issueAreaCode>BUD</issueAreaCode>
      <specific_issues>
        <description>H.R. 4974 &amp; S. 2806, Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2017;
S. 2804, Energy and Water Development and Related Agencies Appropriations Act, 2017 (and related House bill not yet introduced);
P.L. 114-113, Consolidated Appropriations Act, 2016 (H.R. 2029);
Other Labor, Health and Human Services Appropriations (No Bills Introduced); 
Potential Amendments to Appropriations Bills (not introduced);</description>
      </specific_issues>
      <federal_agencies>U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)</federal_agencies>
      <lobbyists>
        <lobbyist>
          <lobbyistFirstName>John</lobbyistFirstName>
          <lobbyistLastName>Ford</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Andrew</lobbyistFirstName>
          <lobbyistLastName>Kaplan</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Heather</lobbyistFirstName>
          <lobbyistLastName>Strawn</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Michael</lobbyistFirstName>
          <lobbyistLastName>Boyd</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Stephen</lobbyistFirstName>
          <lobbyistLastName>Scango</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Daniel</lobbyistFirstName>
          <lobbyistLastName>Bachner</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>General Counsel (1/14-11/15): Office of Sen Chris Coons/Sen. Judiciary Cmte-Oversight Subcmte; Counsel (1/13-12/13): Office of Sen Chris Coons/Sen Judiciary Cmte-Bankruptcy Subcmte; Deputy Counsel (1/12-12/12): Office of Sen Chris Coons</coveredPosition>
          <lobbyistNew>Y</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
      </lobbyists>
      <foreign_entity_issues>
      </foreign_entity_issues>
    </ali_info>
    <ali_info>
      <issueAreaCode>CPT</issueAreaCode>
      <specific_issues>
        <description>H.R. 406 &amp; S. 1767, Combination Drug Development Incentive Act of 2015; 
H.R. 1537 &amp; S. 1878, Advancing Hope Act of 2015;
S. 632, STRONG Patents Act of 2015; 
H.R. 9, Innovation Act;
S. 2733, Venue Equity and Non-Uniformity Elimination Act of 2016;
H.R. 3709, Protecting Consumer Access to Generic Drugs Act of 2013;
H.R. 971 &amp; S. 1421, Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015;
S. 2615, Increasing Competition in Pharmaceuticals Act;
Proposals/Initiatives related to international intellectual property protection;</description>
      </specific_issues>
      <federal_agencies>U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, U.S. Trade Representative (USTR), Patent &amp; Trademark Office (PTO), Health &amp; Human Services - Dept of (HHS), State - Dept of (DOS)</federal_agencies>
      <lobbyists>
        <lobbyist>
          <lobbyistFirstName>John</lobbyistFirstName>
          <lobbyistLastName>Ford</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Andrew</lobbyistFirstName>
          <lobbyistLastName>Kaplan</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Heather</lobbyistFirstName>
          <lobbyistLastName>Strawn</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Michael</lobbyistFirstName>
          <lobbyistLastName>Boyd</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Daniel</lobbyistFirstName>
          <lobbyistLastName>Bachner</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>General Counsel (1/14-11/15): Office of Sen Chris Coons/Sen. Judiciary Cmte-Oversight Subcmte; Counsel (1/13-12/13): Office of Sen Chris Coons/Sen Judiciary Cmte-Bankruptcy Subcmte; Deputy Counsel (1/12-12/12): Office of Sen Chris Coons</coveredPosition>
          <lobbyistNew>Y</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
      </lobbyists>
      <foreign_entity_issues>
      </foreign_entity_issues>
    </ali_info>
    <ali_info>
      <issueAreaCode>HCR</issueAreaCode>
      <specific_issues>
        <description>H.R. 6, 21st Century Cures Act
S. 2700, FDA and NIH Workforce Authorities Modernization Act;
H.R. 3381, Childhood Cancer STAR Act;
Discussions to clarify or reform the 340B program; 
Biologics Price Competition and Innovation Act;
H.R. 1101 &amp; S. 1287, Viral Hepatitis Testing Act; 
Public Law 111-148, The Patient Protection and Affordable Care Act; 
H.R. 471 &amp; S. 483, Ensuring Patient Access and Effective Drug Enforcement of 2015;
H.R. 1725 &amp; S. 480, National All Schedules Prescription Electronic Reporting Reauthorization of 2015; 
H.R. 2228 &amp; S.122, Safe and Affordable Drugs from Canada Act of 2015;
Proposals to address prescription drug abuse; 
Implementation of The Prescription Drug User Fee Act (PDUFA);
Implementation of The Biosimilars User Fee Act (BsUFA);
Public Law 113-54, Drug Quality &amp; Security Act;
H.R. 639 &amp; S. 481, Improving Regulatory Transparency for New Medical Therapies;
H.R. 2570 &amp; S. 1396, Value-Based Insurance Design Seniors Copayment Reduction Act of 2015; 
H.R. 3677 Opioid Abuse Prevention and Treatment Act of 2015;
S. 524, Comprehensive Addiction and Recovery Act of 2016;</description>
      </specific_issues>
      <federal_agencies>U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES</federal_agencies>
      <lobbyists>
        <lobbyist>
          <lobbyistFirstName>Michael</lobbyistFirstName>
          <lobbyistLastName>Boyd</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>John</lobbyistFirstName>
          <lobbyistLastName>Ford</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Andrew</lobbyistFirstName>
          <lobbyistLastName>Kaplan</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Heather</lobbyistFirstName>
          <lobbyistLastName>Strawn</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Daniel</lobbyistFirstName>
          <lobbyistLastName>Bachner</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>General Counsel (1/14-11/15): Office of Sen Chris Coons/Sen. Judiciary Cmte-Oversight Subcmte; Counsel (1/13-12/13): Office of Sen Chris Coons/Sen Judiciary Cmte-Bankruptcy Subcmte; Deputy Counsel (1/12-12/12): Office of Sen Chris Coons</coveredPosition>
          <lobbyistNew>Y</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Stephen</lobbyistFirstName>
          <lobbyistLastName>Scango</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
      </lobbyists>
      <foreign_entity_issues>
      </foreign_entity_issues>
    </ali_info>
    <ali_info>
      <issueAreaCode>MMM</issueAreaCode>
      <specific_issues>
        <description>Policies to enhance patient access to medicines in Medicaid;
Policies to enhance patient access to medicines in Medicare; 
H.R. 3061 &amp; S. 31, Medicare Prescription Drug Price Negotiation Act of 2015;
H.R. 1102 &amp; S. 117, Medicare Prescription Drug Price Negotiation Act;
H.R. 2005 &amp; S. 1083, Medicare Drug Savings Act;
H.R. 3261 &amp; S. 1884, Medicare Prescription Drug Savings and Choice Act of 2015;
Medicare payment proposals;</description>
      </specific_issues>
      <federal_agencies>U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health &amp; Human Services - Dept of (HHS)</federal_agencies>
      <lobbyists>
        <lobbyist>
          <lobbyistFirstName>John</lobbyistFirstName>
          <lobbyistLastName>Ford</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Andrew</lobbyistFirstName>
          <lobbyistLastName>Kaplan</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Heather</lobbyistFirstName>
          <lobbyistLastName>Strawn</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Michael</lobbyistFirstName>
          <lobbyistLastName>Boyd</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Daniel</lobbyistFirstName>
          <lobbyistLastName>Bachner</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>General Counsel (1/14-11/15): Office of Sen Chris Coons/Sen. Judiciary Cmte-Oversight Subcmte; Counsel (1/13-12/13): Office of Sen Chris Coons/Sen Judiciary Cmte-Bankruptcy Subcmte; Deputy Counsel (1/12-12/12): Office of Sen Chris Coons</coveredPosition>
          <lobbyistNew>Y</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Stephen</lobbyistFirstName>
          <lobbyistLastName>Scango</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
      </lobbyists>
      <foreign_entity_issues>
      </foreign_entity_issues>
    </ali_info>
    <ali_info>
      <issueAreaCode>TAX</issueAreaCode>
      <specific_issues>
        <description>H.R. 880, American Research and Competitiveness Act of 2015; 
H.R. 1430, Permanent CFC Look-Through Act;
H.R. 415 &amp; S. 198, Stop Corporate Inversions Act; 
S. 1946, Tax Relief Extension Act of 2015;
H.R. 1, Tax Reform Act of 2014;
Administrations Tax Reform and 2017 Budget Proposals; 
Senate and House Committee Tax Reform Proposals;
Puerto Rican Economy and Debt Relief Proposals (no bills introduced);
Reps. Boustany and Neal: "Innovation Promotion Act" Discussion Draft
Proposals to reform domestic and international tax structures (no bills introduced);</description>
      </specific_issues>
      <federal_agencies>U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES</federal_agencies>
      <lobbyists>
        <lobbyist>
          <lobbyistFirstName>Michael</lobbyistFirstName>
          <lobbyistLastName>Boyd</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Andrew</lobbyistFirstName>
          <lobbyistLastName>Kaplan</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Heather</lobbyistFirstName>
          <lobbyistLastName>Strawn</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>John</lobbyistFirstName>
          <lobbyistLastName>Ford</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Daniel</lobbyistFirstName>
          <lobbyistLastName>Bachner</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>General Counsel (1/14-11/15): Office of Sen Chris Coons/Sen. Judiciary Cmte-Oversight Subcmte; Counsel (1/13-12/13): Office of Sen Chris Coons/Sen Judiciary Cmte-Bankruptcy Subcmte; Deputy Counsel (1/12-12/12): Office of Sen Chris Coons</coveredPosition>
          <lobbyistNew>Y</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
      </lobbyists>
      <foreign_entity_issues>
      </foreign_entity_issues>
    </ali_info>
    <ali_info>
      <issueAreaCode>TRD</issueAreaCode>
      <specific_issues>
        <description>Trans-Atlantic Trade and Investment Partnership; 
Trans-Pacific Partnership Agreement; 
Trade Promotion Authority;
Columbia-America Free Trade Agreement;
Saudi Arabia Cancellation of Tender Issue;
Japan Biannual Re-Pricing Issue;
Plan COLOMBIA;</description>
      </specific_issues>
      <federal_agencies>U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, U.S. Trade Representative (USTR), Patent &amp; Trademark Office (PTO), Natl Security Council (NSC), Commerce - Dept of (DOC), State - Dept of (DOS)</federal_agencies>
      <lobbyists>
        <lobbyist>
          <lobbyistFirstName>Andrew</lobbyistFirstName>
          <lobbyistLastName>Kaplan</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Michael</lobbyistFirstName>
          <lobbyistLastName>Boyd</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Steven</lobbyistFirstName>
          <lobbyistLastName>Scango</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Heather</lobbyistFirstName>
          <lobbyistLastName>Strawn</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>John</lobbyistFirstName>
          <lobbyistLastName>Ford</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>Daniel</lobbyistFirstName>
          <lobbyistLastName>Bachner</lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>General Counsel (1/14-11/15): Office of Sen Chris Coons/Sen. Judiciary Cmte-Oversight Subcmte; Counsel (1/13-12/13): Office of Sen Chris Coons/Sen Judiciary Cmte-Bankruptcy Subcmte; Deputy Counsel (1/12-12/12): Office of Sen Chris Coons</coveredPosition>
          <lobbyistNew>Y</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
        <lobbyist>
          <lobbyistFirstName>
          </lobbyistFirstName>
          <lobbyistLastName>
          </lobbyistLastName>
          <lobbyistSuffix>
          </lobbyistSuffix>
          <coveredPosition>
          </coveredPosition>
          <lobbyistNew>N</lobbyistNew>
        </lobbyist>
      </lobbyists>
      <foreign_entity_issues>
      </foreign_entity_issues>
    </ali_info>
  </alis>
  <updates>
    <clientAddress>
    </clientAddress>
    <clientCity>
    </clientCity>
    <clientState>
    </clientState>
    <clientZip>
    </clientZip>
    <clientZipext>
    </clientZipext>
    <clientCountry>
    </clientCountry>
    <prinClientCity>
    </prinClientCity>
    <prinClientState>
    </prinClientState>
    <prinClientZip>
    </prinClientZip>
    <prinClientZipext>
    </prinClientZipext>
    <prinClientCountry>
    </prinClientCountry>
    <generalDescription>
    </generalDescription>
    <inactive_lobbyists>
      <inactive_lobbyist>
        <firstName>
        </firstName>
        <lastName>
        </lastName>
        <suffix>
        </suffix>
      </inactive_lobbyist>
      <inactive_lobbyist>
        <firstName>
        </firstName>
        <lastName>
        </lastName>
        <suffix>
        </suffix>
      </inactive_lobbyist>
      <inactive_lobbyist>
        <firstName>
        </firstName>
        <lastName>
        </lastName>
        <suffix>
        </suffix>
      </inactive_lobbyist>
      <inactive_lobbyist>
        <firstName>
        </firstName>
        <lastName>
        </lastName>
        <suffix>
        </suffix>
      </inactive_lobbyist>
    </inactive_lobbyists>
    <inactive_ALIs>
      <ali_Code>
      </ali_Code>
      <ali_Code>
      </ali_Code>
      <ali_Code>
      </ali_Code>
      <ali_Code>
      </ali_Code>
      <ali_Code>
      </ali_Code>
      <ali_Code>
      </ali_Code>
      <ali_Code>
      </ali_Code>
      <ali_Code>
      </ali_Code>
      <ali_Code>
      </ali_Code>
    </inactive_ALIs>
    <affiliatedUrl>
    </affiliatedUrl>
    <affiliatedOrgs>
      <affiliatedOrg>
        <affiliatedOrgName>
        </affiliatedOrgName>
        <affiliatedOrgAddress>
        </affiliatedOrgAddress>
        <affiliatedOrgCity>
        </affiliatedOrgCity>
        <affiliatedOrgState>
        </affiliatedOrgState>
        <affiliatedOrgZip>
        </affiliatedOrgZip>
        <affiliatedOrgCountry>
        </affiliatedOrgCountry>
        <affiliatedPrinOrgCity>
        </affiliatedPrinOrgCity>
        <affiliatedPrinOrgState>
        </affiliatedPrinOrgState>
        <affiliatedPrinOrgCountry>
        </affiliatedPrinOrgCountry>
      </affiliatedOrg>
      <affiliatedOrg>
        <affiliatedOrgName>
        </affiliatedOrgName>
        <affiliatedOrgAddress>
        </affiliatedOrgAddress>
        <affiliatedOrgCity>
        </affiliatedOrgCity>
        <affiliatedOrgState>
        </affiliatedOrgState>
        <affiliatedOrgZip>
        </affiliatedOrgZip>
        <affiliatedOrgCountry>
        </affiliatedOrgCountry>
        <affiliatedPrinOrgCity>
        </affiliatedPrinOrgCity>
        <affiliatedPrinOrgState>
        </affiliatedPrinOrgState>
        <affiliatedPrinOrgCountry>
        </affiliatedPrinOrgCountry>
      </affiliatedOrg>
    </affiliatedOrgs>
    <inactiveOrgs>
      <inactiveOrgName>
      </inactiveOrgName>
      <inactiveOrgName>
      </inactiveOrgName>
      <inactiveOrgName>
      </inactiveOrgName>
    </inactiveOrgs>
    <foreignEntities>
      <foreignEntity>
        <name>
        </name>
        <address>
        </address>
        <city>
        </city>
        <state>
        </state>
        <country>
        </country>
        <prinCity>
        </prinCity>
        <prinState>
        </prinState>
        <prinCountry>
        </prinCountry>
        <contribution>
        </contribution>
        <ownership_Percentage>
        </ownership_Percentage>
      </foreignEntity>
    </foreignEntities>
    <inactive_ForeignEntities>
      <inactive_ForeignEntity>
      </inactive_ForeignEntity>
      <inactive_ForeignEntity>
      </inactive_ForeignEntity>
      <inactive_ForeignEntity>
      </inactive_ForeignEntity>
      <inactive_ForeignEntity>
      </inactive_ForeignEntity>
      <inactive_ForeignEntity>
      </inactive_ForeignEntity>
      <inactive_ForeignEntity>
      </inactive_ForeignEntity>
    </inactive_ForeignEntities>
  </updates>
</LOBBYINGDISCLOSURE2>